Literature DB >> 27143704

Risk of Complications after Thyroidectomy and Parathyroidectomy: A Case Series with Planned Chart Review.

Charles Meltzer1, Marc Klau2, Deepak Gurushanthaiah3, Hari Titan4, Di Meng4, Linda Radler5, Alvina Sundang5.   

Abstract

OBJECTIVE: To develop a predictive model for the risk of complications after thyroid and parathyroid surgery. STUDY
DESIGN: Case series with planned chart review of patients undergoing surgery, 2007-2013.
SETTING: Kaiser Permanente Northern California and Kaiser Permanente Southern California. SUBJECTS AND METHODS: Patients (N = 16,458) undergoing thyroid and parathyroid procedures were randomly assigned to model development and validation groups. We used univariate analysis to assess relationships between each of 28 predictor variables and 30-day complication rates. We subsequently entered all variables into a recursive partitioning decision tree analysis, with P < .05 as the basis for branching.
RESULTS: Among patients undergoing thyroidectomies, the most important predictor variable was thyroid cancer. For patients with thyroid cancer, additional risk predictors included coronary artery disease and central neck dissection. For patients without thyroid cancer, additional predictors included coronary artery disease, dyspnea, complete thyroidectomy, and lobe size. Among patients undergoing parathyroidectomies, the most important predictor variable was coronary artery disease, followed by cerebrovascular disease and chronic kidney disease. The model performed similarly in the validation groups.
CONCLUSION: For patients undergoing thyroid surgery, 7 of 28 predictor variables accounted for statistically significant differences in the risk of 30-day complications; for patients undergoing parathyroid surgery, 3 variables accounted for significant differences in risk. This study forms the foundation of a parsimonious model to predict the risk of complications among patients undergoing thyroid and parathyroid surgery. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

Entities:  

Keywords:  complications; parathyroidectomy; patient safety; surgical outcomes; thyroidectomy

Mesh:

Year:  2016        PMID: 27143704     DOI: 10.1177/0194599816644727

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.

Authors:  Kepal N Patel; Trevor E Angell; Joshua Babiarz; Neil M Barth; Thomas Blevins; Quan-Yang Duh; Ronald A Ghossein; R Mack Harrell; Jing Huang; Giulia C Kennedy; Su Yeon Kim; Richard T Kloos; Virginia A LiVolsi; Gregory W Randolph; Peter M Sadow; Michael H Shanik; Julie A Sosa; S Thomas Traweek; P Sean Walsh; Duncan Whitney; Michael W Yeh; Paul W Ladenson
Journal:  JAMA Surg       Date:  2018-09-01       Impact factor: 14.766

2.  Evidence-Based Workflows for Thyroid and Parathyroid Surgery.

Authors:  Charles Meltzer; Amer Budayr; Annette Chavez; Richard Dlott; William Greif; Deepak Gurushanthaiah; Andrew Klonecke; Matthew Lando; Joyce Leary; Sundeep Nayak; Ryan Niederkohr; Judith Park; Alison Savitz; Henry Schwartz
Journal:  Perm J       Date:  2016-07-29

3.  Utility of intraoperative nerve monitoring in thyroid surgery: 20-year experience with 1418 cases.

Authors:  Sameep Kadakia; Moustafa Mourad; Shirley Hu; Ryan Brown; Thomas Lee; Yadranko Ducic
Journal:  Oral Maxillofac Surg       Date:  2017-06-02

4.  Ultrasound-guided ethanol injection for the treatment of parathyroid adenoma: A prospective self-controlled study.

Authors:  Amir Ali Yazdani; Nooshin Khalili; Mansour Siavash; Albert Shemian; Amir Reza Goharian; Mozhgan Karimifar; Babak Tavakoli; Maryam Yazdi
Journal:  J Res Med Sci       Date:  2020-10-28       Impact factor: 1.852

5.  The Ongoing Debate Regarding Completion Thyroidectomy Versus Primary Thyroid Surgery for Low and Intermediate Differentiated Thyroid Carcinoma: A Meta-Analysis.

Authors:  Hyder Mirghani; Ibrahim A Altedlawi Albalawi
Journal:  Cureus       Date:  2020-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.